Skip to main content
. 2021 May 18;65(6):e00184-21. doi: 10.1128/AAC.00184-21

FIG 12.

FIG 12

Examples of β-lactamase inhibitors in different inhibitor classes. β-Lactam ring-based inhibitors, diazabicyclooctanones, and boronates each block divided into investigational compounds (top), compounds in clinical trials (middle), and inhibitors approved in clinical use (bottom). Inhibitors in red and italics do not effectively inhibit OXA-48; inhibitors in black show inhibitory activity.